“Teenage Blood Has Power to Restore Youth” (Article in “New Scientist Weekly”), New Scientist, Nov, 19, 2016

“Blood plasma from young people has rejuvenated old mice, boosting their memory, cognition and physical activity. The method shows promise for use in people… Earlier research found that injecting old mice with plasma – the liquid part of blood – from young mice can invigorate the brain and muscle… After receiving two human plasma injections a week, for three weeks, the middle age mice ran around like young mice. Their memories seemed to improve, and they were much better at remembering the route around the maze than untreated mice.

Young human plasma improves cognition… The blood of young people must have something in it that’s important for keeping them young… some factors in young blood might be responsible for these benefits. Anti-aging treatment [can benefit from it].”
(New Scientist, 19 November 2016, p. 10)

Observing the perspectives of our country’s development in the 21st century and juxtaposing it with the discovery of the human blood plasma’s value for prolonging life of the aging, we can deduce how much free space in time the successes of anti-aging treatment by the blood of the young will open for the members of financial elite.

It can be only imagined how young people from the poor segments of the population will be desperately happy to sell their blood for the sake of longevity of 1–2%. Blood banks will become as commercially savvy as commercial banks. The necessity to separate plasma from blood on the mass scale may start a growing industry with millionaires and billionaires on top. May be, intensification of blood trade inside US will raise GDP to unseen heights. Interesting, how availability of multinational blood plasma will intensify international trade and what will be the price difference, for example, between the plasma of white and colored youth. And, of course, numerous other questions will pop up, which will be successfully answered by the honorable practitioners of anti-aging blood industry in our promising future.